StockData
Clover Health Investments, Corp. logo

Clover Health Investments, Corp. (CLOV) stock

CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$4.88−0.09 (-1.81%)

Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –

Earnings

Clover Health Investments's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 25, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$759.00M
EPS, Q3 FY2026
$0.01
Latest guidance
Issued
Nov 4, 2026 · 5 items

Quarterly results

Revenue and earnings per share from each of Clover Health Investments's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 25, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026after the close$759.00M–$0.01Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026after the close$743.17M+55.5%$0.05Release
Q1 FY2026ended Mar 31, 2026May 6, 2026after the close$749.00M+62.0%$0.05Release
Q4 FY2025ended Dec 31, 2025Feb 26, 2026after the close–––Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025after the close$478.00M+34.2%–Release
Q1 FY2025ended Mar 31, 2025May 6, 2025after the close$462.30M+33.3%$0.00Release
Q4 FY2024ended Dec 31, 2024Feb 27, 2025after the close$337.00M-34.0%-$0.04Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024after the close–––Release
Q2 FY2024ended Jun 30, 2024Aug 5, 2024after the close$356.30M-30.6%$0.01Release
Q1 FY2024ended Mar 31, 2024May 7, 2024after the close$346.90M-34.3%-$0.05Release
Q4 FY2023ended Dec 31, 2023Mar 12, 2024after the close$510.30M-43.2%–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Clover Health Investments's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Total revenuesFY2026$2.97B – $3.00B–NewNov 4, 2026
Total revenuesFY2026$2.92B – $3.00B$2.81B – $2.92BRaisedAug 5, 2026
Consolidated Gross Profitnon-GAAPFY2026$470.00M – $510.00M$470.00M – $510.00MReaffirmedMay 6, 2026
Adjusted EBITDA profitabilitynon-GAAPFY2026$75.00M – $85.00M–NewNov 4, 2026
Adjusted EBITDA profitabilitynon-GAAPFY2026$70.00M – $85.00M$50.00M – $70.00MRaisedAug 5, 2026
Average Medicare Advantage membershipFY2026157,000 – 158,000–NewNov 4, 2026
Average Medicare Advantage membershipFY2026156,000 – 158,000154,000 – 158,000RaisedAug 5, 2026
Consolidated Gross Profitnon-GAAPFY2026$540.00M – $555.00M–NewNov 4, 2026
Consolidated Gross Profitnon-GAAPFY2026$525.00M – $555.00M–NewAug 5, 2026
GAAP Net IncomeGAAPFY2026$25.00M – $35.00M–NewNov 4, 2026
GAAP Net IncomeGAAPFY2026$20.00M – $35.00M$0 – $20.00MRaisedAug 5, 2026

Guidance history

Every forecast Clover Health Investments put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 4, 2026Adjusted EBITDA profitabilityFY2026$75.00M – $85.00MNew
Nov 4, 2026Average Medicare Advantage membershipFY2026157,000 – 158,000New
Nov 4, 2026GAAP Net IncomeFY2026$25.00M – $35.00MNew
Nov 4, 2026Consolidated Gross ProfitFY2026$540.00M – $555.00MNew
Nov 4, 2026Total revenuesFY2026$2.97B – $3.00BNew
Aug 5, 2026Adjusted EBITDA profitabilityFY2026$70.00M – $85.00MRaised
Aug 5, 2026Consolidated Gross ProfitFY2026$525.00M – $555.00MNew
Aug 5, 2026Average Medicare Advantage membershipFY2026156,000 – 158,000Raised
Aug 5, 2026GAAP Net IncomeFY2026$20.00M – $35.00MRaised
Aug 5, 2026Total revenuesFY2026$2.92B – $3.00BRaised
May 6, 2026Adjusted EBITDA profitabilityFY2026$50.00M – $70.00MReaffirmed
May 6, 2026Consolidated Gross ProfitFY2026$470.00M – $510.00MReaffirmed
May 6, 2026Average Medicare Advantage membershipFY2026154,000 – 158,000Reaffirmed
May 6, 2026GAAP Net IncomeFY2026$0 – $20.00MReaffirmed
May 6, 2026Total revenuesFY2026$2.81B – $2.92BReaffirmed
Feb 26, 2026Adjusted EBITDAFY2026$50.00M – $70.00MNew
Feb 26, 2026Consolidated Gross profitFY2026$470.00M – $510.00MNew
Feb 26, 2026GAAP Net IncomeFY2026$0 – $20.00MNew
Feb 26, 2026Average Medicare Advantage membershipFY2026154,000 – 158,000New
Feb 26, 2026Total revenuesFY2026$2.81B – $2.92BNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Clover Health Investments filed with the SEC as exhibits to Form 8-K or 6-K

  1. Clover Health Reports Third Quarter 2026 Results
    Results
  2. Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027
    Update
  3. 8-K exhibit EX-99.1
    Update
  4. Clover Health Reports Second Quarter 2026 Results
    Results
  5. 8-K exhibit EX-99.1
    Update
  6. Clover Health Reports First Quarter 2026 Results
    Results
  7. 8-K exhibit EX-99.1
    News
  8. 8-K/A exhibit EX-99.1
    Update
  9. Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance
    Results
  10. 8-K exhibit EX-99.1
    Update
  11. Investor Presentation January 2026 LGTMs: Date: Andrew T. (CEO) LGTM 1/8/26 Peter K. (CFO) LGTM 1.7.26 Karen S. (Legal) LGTM 1.7.26
    Update
  12. 8-K exhibit EX-99.1
    Update
  13. 8-K exhibit EX-99.1
    Update
  14. Clover Health Reports Third Quarter 2025 Results
    Update
  15. Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027
    Update

See a number that looks wrong?